A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural ?-aminobutyric acid (GABA) binding
- 1 September 1987
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 2 (3) , 201-205
- https://doi.org/10.1007/bf00999611
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Brain γ-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma γ-aminobutyric acid-like activityGastroenterology, 1987
- Postsynaptic ?-aminobutyric acid receptors in hepatic coma following portacaval shunt and hepatic artery ligation in the ratMetabolic Brain Disease, 1987
- In vivo studies of GABAergic effects in experimental hepatic encephalopathyHepatology, 1986
- Supersensitivity of Benzodiazepine Receptors in Hepatic Encephalopathy Due to Fulminant Hepatic Failure in the Rat: Reversal by a Benzodiazepine AntagonistClinical Science, 1984
- Changes in the Status of Neurotransmitter Receptors in a Rabbit Model of Hepatic EncephalopathyHepatology, 1984
- Toxins in Hepatic Encephalopathy: The Role of the Synergistic Effect of Ammonia, Mercaptans and Short Chain Fatty AcidsPublished by Springer Nature ,1984
- GAMMA-AMINOBUTYRIC ACID AND BENZODIAZEPINE RECEPTORS IN AN ANIMAL-MODEL OF FULMINANT HEPATIC-FAILURE1983
- Experimental Hepatic Encephalopathy: Changes in the Binding of γ-Aminobutyric AcidScience, 1982